No Data
No Data
Tofflon Science and Technology Group (300171.SZ): Some fundraising projects are proposed to be postponed.
On December 20, Glonghui reported that Tofflon Science and Technology Group (300171.SZ) held the fourteenth (temporary) meeting of the sixth Board of Directors and the twelfth (temporary) meeting of the sixth Supervisory Board on December 20, 2024. It reviewed and approved the "Proposal for the Postponement of Some Fundraising Project" and agreed to delay the date for the "Jiangsu Biomedical Equipment Industrialization Base Project" to achieve the predetermined usable state from January 10, 2025, to January 1, 2026, in accordance with the current actual progress of the fundraising projects, provided that there are no changes to the implementing entities, uses of raised funds, and investment scale.
Tofflon Science and Technology Group (300171.SZ): has two overseas manufacturing bases in India and Italy.
On December 19, according to Glenwood, Tofflon Science and Technology Group (300171.SZ) stated on the investor interaction platform that the company has two overseas production bases in India and Italy. The company will continue to increase overseas investment and layout, improve the marketing network, and promote the Global Strategy process.
Tofflon Science and Technology Group's (SZSE:300171) Earnings Growth Rate Lags the 16% CAGR Delivered to Shareholders
Individual Investors Are Tofflon Science and Technology Group Co., Ltd.'s (SZSE:300171) Biggest Owners and Were Hit After Market Cap Dropped CN¥411m
Tofflon Science and Technology Group (300171.SZ): Shanghai Bohao currently offers services mainly including chip genetic testing, single-cell sequencing, etc.
Gelonghui November 6th | Tofflon Science and Technology Group (300171.SZ) stated on the investor interaction platform that Shanghai Bohao currently provides services mainly including chip genetic testing, single-cell sequencing, etc.
Dongfulong: 2024 third quarter report